Alphatec Holdings' Promising Outlook Supported by Strong Growth and Strategic Investments, Leading to Increased Price TargetWe reiterate Buy, increase PT to $19, and would be buyers at current levels. A Strong Beat: ATEC preannounced Q4 revenue of $175.5-177 MM (+29-31%), 3.5% above cons of $170.4 MM (+23.5%). Surgical revenue of $155.6-156.6 MM grew ~27-28%, driven by continued strong surgical volume growth, while EOS revenue of $19.9-20.4 MM grew ~33-36%. Full year revenue grew 27% to $610.3-611.8 MM, including Surgical revenue of $543.6-544.6 MM (~29%), and EOS revenue of $66.7-67.2 MM (12-13%). CF was ~$8 MM, vs implied guidance of $1-11 MM.